Loading market dashboard
Relay Therapeutics, Inc.
RLAYHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Relay Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $466.63M | $359.89M - $729.71M | -$466.63M | -$0.123 | 4 |
| Dec 2029 | $186.63M | $143.94M - $291.85M | -$186.63M | -$1.007 | 4 |
| Dec 2028 | $55.39M | $42.72M - $86.61M | -$55.39M | -$1.52 | 9 |
| Dec 2027 | $19.63M | $15.14M - $30.70M | -$19.63M | -$1.619 | 7 |
| Dec 2026 | $11.88M | $4.28M - $22.82M | -$11.88M | -$1.57 | 9 |
| Dec 2025 | $12.81M | $5.49M - $25.20M | -$12.81M | -$1.732 | 7 |
| Dec 2024 | $15.08M | $8.07M - $48.43M | -$15.08M | -$2.508 | 9 |
| Dec 2023 | $35.21M | $27.15M - $55.06M | -$35.21M | -$2.527 | 5 |
| Dec 2022 | $4.46M | $1.80M - $9.06M | -$252.99M | -$2.742 | 3 |
| Dec 2021 | $6.41M | $2.59M - $13.03M | -$574.20M | -$3.688 | 4 |
| Dec 2020 | $38.75M | $15.66M - $78.72M | -$35.90M | -$4.81 | 4 |